Solventum Corp (SOLV)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$87.81
+0.41%
Investingg Score
61.3 / 100
Hold
Business overview
- Operating margin stands at 26.2%.
- Gross margin is reported at 53.5%.
- Free cash flow margin is -0.1%.
These profitability metrics indicate solid core operations, though slightly offset by negative free cash flow generation.
Financial health
- Free cash flow yield is registered at -0.1%.
- FCF margin sits at -0.1%.
These figures highlight near-term cash flow pressures that represent an area of financial uncertainty for the company.
- Gross Margin
- 53.5%
- Operating Margin
- 26.2%
- Current Ratio
- 1.2x
- Debt / Equity
- 1.00
- Free Cash Flow (TTM)
- $-0.0B
- Interest Coverage
- 6x
Valuation
- Price-to-earnings ratio is 10.43.
- Forward P/E ratio is 12.24.
- EV/EBITDA ratio is 8.38.
- Price-to-sales ratio is 1.8.
These valuation multiples suggest the stock is priced reasonably relative to its current earnings and sales base.
- P/E (TTM)
- 10.4x
- Forward P/E
- 12.2x
- Price / Sales
- 1.8x
- EV / EBITDA
- 8.4x
- FCF Yield
- -0.1%
Key risks
- Negative free cash flow margin of -0.1% introduces cash generation uncertainties.
- Subdued revenue growth year-over-year of 0.9% limits top-line expansion.
- Balance sheet score of 43 indicates potential structural or leverage risks.
Market cap $15.2B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze SOLV with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.